The Calmer Co International Limited (ASX:CCO)

Market Cap	10.22M
Revenue (ttm)	7.20M
Net Income (ttm)	-4.45M
Shares Out	2.55B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,594,110
Average Volume	5,954,374
Open	0.0040
Previous Close	0.0040
Day's Range	0.0030 - 0.0040
52-Week Range	0.0030 - 0.0200
Beta	1.38
RSI	43.92
Earnings Date	May 29, 2025

About ASX:CCO

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; cold pressed shots and kava under the Taki Mai brand name; hemp, CBD oils, topical products, and kava tinctures under Danodan brand name; and nutraceuticals. It also markets Leilo kava beverages. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CCO

Financial Performance

In 2024, ASX:CCO's revenue was 4.26 million, an increase of 138.92% compared to the previous year's 1.78 million. Losses were -3.73 million, -30.37% less than in 2023.